Pacira BioSciences, Inc. EPS (Earnings per Share) 2009–2025
Pacira BioSciences, Inc. reported $0.16 of earnings per share for fiscal 2025. That was 107.4% higher than fiscal 2024. Compared with fiscal 2020, the change was -95.2%.
| Fiscal year | EPS (Earnings per Share) | Change (YoY) |
|---|---|---|
| FY 2025 | $0.16 | +107.4% |
| FY 2024 | $-2.15 | -341.6% |
| FY 2023 | $0.89 | +161.8% |
| FY 2022 | $0.34 | -63.0% |
| FY 2021 | $0.92 | -72.4% |
| FY 2020 | $3.33 | +1333.3% |
| FY 2019 | $-0.27 | -2600.0% |
| FY 2018 | $-0.01 | +99.1% |
| FY 2017 | $-1.07 | -4.9% |
| FY 2016 | $-1.02 | -2650.0% |
| FY 2015 | $0.04 | +110.3% |
| FY 2014 | $-0.39 | +79.8% |
| FY 2013 | $-1.93 | — |
| FY 2012 | $0.00 | — |
| FY 2011 | $0.00 | — |
| FY 2010 | $0.00 | — |
| FY 2009 | $0.00 | — |
Source: Pacira BioSciences, Inc. SEC filings — income statement (10-K), split-adjusted. Computed deterministically; refreshed nightly (last updated August 2, 2026). Open PCRX 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
Pacira BioSciences, Inc. reported $0.16 of earnings per share for fiscal 2025. That was 107.4% higher than fiscal 2024. Compared with fiscal 2020, the change was -95.2%. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for Pacira BioSciences, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freePacira BioSciences, Inc. — frequently asked questions
What is Pacira BioSciences, Inc.'s earnings per share?
Pacira BioSciences, Inc. (PCRX) reported earnings per share of $0.16 for fiscal year 2025, per its SEC filings.
Where does this data come from?
Figures are computed from Pacira BioSciences, Inc.'s official SEC filings (income statement (10-K), split-adjusted), refreshed nightly. Not investment advice.